Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


26.11.2018

1 BJU Int
1 BMC Cancer
1 Br J Cancer
1 Cancer
2 Eur Radiol
3 Eur Urol
2 Int J Radiat Oncol Biol Phys
4 Int J Urol
1 J Nucl Med
3 Prostate
1 Semin Oncol
1 Urology


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BJU Int

  1. ROCCO B, Sighinolfi MC, Sandri M, Puliatti S, et al
    A novel nomogram for predicting ECE of prostate cancer.
    BJU Int. 2018;122:916-918.
    PubMed     Text format    


    BMC Cancer

  2. JOACHIM C, Veronique-Baudin J, Ulric-Gervaise S, Macni J, et al
    Pattern of care of prostate cancer patients across the Martinique: results of a population-based study in the Caribbean.
    BMC Cancer. 2018;18:1130.
    PubMed     Text format     Abstract available


    Br J Cancer

  3. SCHMIDT L, Moller M, Haldrup C, Strand SH, et al
    Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases.
    Br J Cancer. 2018 Nov 19. pii: 10.1038/s41416-018-0321.
    PubMed     Text format     Abstract available


    Cancer

  4. BORNO HT, Lichtensztajn DY, Gomez SL, Palmer NR, et al
    Differential use of medical versus surgical androgen deprivation therapy for patients with metastatic prostate cancer.
    Cancer. 2018 Nov 16. doi: 10.1002/cncr.31826.
    PubMed     Text format     Abstract available


    Eur Radiol

  5. GREER MD, Lay N, Shih JH, Barrett T, et al
    Computer-aided diagnosis prior to conventional interpretation of prostate mpMRI: an international multi-reader study.
    Eur Radiol. 2018;28:4407-4417.
    PubMed     Text format     Abstract available

  6. DIKAIOS N, Giganti F, Sidhu HS, Johnston EW, et al
    Multi-parametric MRI zone-specific diagnostic model performance compared with experienced radiologists for detection of prostate cancer.
    Eur Radiol. 2018 Nov 19. pii: 10.1007/s00330-018-5799.
    PubMed     Text format     Abstract available


    Eur Urol

  7. O'SULLIVAN JM, Heinrich D, James ND, Nilsson S, et al
    The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer.
    Eur Urol. 2018 Nov 16. pii: S0302-2838(18)30857.
    PubMed     Text format    

  8. DE MAN K, Ost P
    Re: [(177)Lu]-PSMA-617 Radionuclide Treatment in Patients with Metastatic Castration-resistant Prostate Cancer (LuPSMA Trial): A Single-centre, Single-arm, Phase 2 Study.
    Eur Urol. 2018 Nov 14. pii: S0302-2838(18)30859.
    PubMed     Text format    

  9. SHINDE A, Li R, Amini A, Glaser S, et al
    Re: Liselotte M.S. Boeve, Maarten C.C.M. Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primar
    Eur Urol. 2018 Nov 18. pii: S0302-2838(18)30865.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  10. WORTEL RC, Oomen-de Hoop E, Heemsbergen WD, Pos FJ, et al
    Moderate hypofractionation in intermediate and high risk, localized prostate cancer: Health-related quality of life from the randomized, phase 3 HYPRO trial.
    Int J Radiat Oncol Biol Phys. 2018 Nov 17. pii: S0360-3016(18)34006.
    PubMed     Text format     Abstract available

  11. ALAYED Y, Cheung P, Vesprini D, Liu S, et al
    SABR in high risk prostate cancer: outcomes from two prospective clinical trials with and without elective nodal irradiation.
    Int J Radiat Oncol Biol Phys. 2018 Nov 13. pii: S0360-3016(18)33997.
    PubMed     Text format     Abstract available


    Int J Urol

  12. HAYASHI T, Fujita K, Matsushita M, Hayashi Y, et al
    Metformin inhibits prostate cancer growth induced by a high-fat diet in Pten-deficient model mice.
    Int J Urol. 2018 Nov 20. doi: 10.1111/iju.13847.
    PubMed     Text format    

  13. PATEL DN, Chapin BF, Freedland SJ
    Response to Editorial Comment to Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital.
    Int J Urol. 2018 Nov 20. doi: 10.1111/iju.13861.
    PubMed     Text format    

  14. HAKOZAKI Y, Matsushima H, Murata T, Masuda T, et al
    Detection rate of clinically significant prostate cancer in magnetic resonance imaging and ultrasonography-fusion transperineal targeted biopsy for lesions with a prostate imaging reporting and data system version 2 score of 3-5.
    Int J Urol. 2018 Nov 21. doi: 10.1111/iju.13842.
    PubMed     Text format     Abstract available

  15. SHIOTA M, Namitome R, Kobayashi T, Inokuchi J, et al
    Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with de novo metastatic prostate cancer.
    Int J Urol. 2018 Nov 21. doi: 10.1111/iju.13870.
    PubMed     Text format    


    J Nucl Med

  16. BEHR SC, Aggarwal R, Van Brocklin HF, Flavell RR, et al
    First-in-Human Phase I study of CTT1057, a Novel (18)F Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate Specific Membrane Antigen in Prostate Cancer.
    J Nucl Med. 2018 Nov 21. pii: jnumed.118.220715. doi: 10.2967/jnumed.118.220715.
    PubMed     Text format     Abstract available


    Prostate

  17. GIRI VN, Hegarty SE, Hyatt C, O'Leary E, et al
    Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing.
    Prostate. 2018 Nov 18. doi: 10.1002/pros.23739.
    PubMed     Text format     Abstract available

  18. ALANEE S, Holland B, Clemons J, Dynda D, et al
    Death due to sepsis in patients diagnosed with prostate cancer.
    Prostate. 2018 Nov 18. doi: 10.1002/pros.23735.
    PubMed     Text format     Abstract available

  19. MIYAKE M, Tanaka N, Hori S, Ohnishi S, et al
    Dual benefit of supplementary oral 5-aminolevulinic acid to pelvic radiotherapy in a syngenic prostate cancer model.
    Prostate. 2018 Nov 18. doi: 10.1002/pros.23740.
    PubMed     Text format     Abstract available


    Semin Oncol

  20. INGROSSO G, Detti B, Scartoni D, Lancia A, et al
    Current therapeutic options in metastatic castration-resistant prostate cancer.
    Semin Oncol. 2018 Oct 30. pii: S0093-7754(17)30050.
    PubMed     Text format     Abstract available


    Urology

  21. DE RIESE W, Verlage K, Grand R, de Riese CS, et al
    Re: Turini et al.: The State of Prescreening Discussions About Prostate-specific Antigen Testing Following Implementation of the 2012 United States Preventive Services Task Force Statement (Urology 2017;104:122-130).
    Urology. 2018;114:246.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: